Table 2
Predicted five-year relative survival ratios (RSRs) for women and percentage unit superiority of estimates to corresponding estimates for men, by cancer, ages 15 to 99, Canada excluding Quebec, 2004-to-2008 period^Note † Table 2
Predicted five-year relative survival ratios (RSRs) for women and percentage unit superiority of estimates to corresponding estimates for men, by cancer, ages 15 to 99, Canada excluding Quebec, 2004-to-2008 period^Note †

Table 2
Predicted five-year relative survival ratios (RSRs) for women and percentage unit superiority of estimates to corresponding estimates for men, by cancer, ages 15 to 99, Canada excluding Quebec, 2004-to-2008 period^†
Table summary
This table displays the results of Predicted five-year relative survival ratios (RSRs) for women and percentage unit superiority of estimates to corresponding estimates for men. The information is grouped by Cancer (appearing as row headers), Crude RSR, Age-standardized RSR, Women (%), Women - Men, % units, 95% confidence interval and % units, calculated using from and to units of measure (appearing as column headers).
Cancer	Crude RSR				Age-standardized RSR
	Women (%)	Women - Men			Women (%)	Women - Men
		% units	95% confidence interval			% units	95% confidence interval
		% units	from	to		% units	from	to
All cancers^Note ‡	49.6	4.6	4.2	4.9	48.4	3.8	3.5	4.2
Case-mix-standardized	48.8	2.3	1.9	2.6	48.9	2.9	2.6	3.3
Oral cavity and pharynx	66.4	5.3	3.2	7.4	66.6	6.2	4.1	8.3
Esophagus	15.0	1.8	-0.6	4.2	16.8	3.9	1.3	6.5
Stomach	26.5	3.2	1.2	5.1	26.6	3.6	1.6	5.5
Colon	63.4	0.8	-0.3	1.9	63.9	1.7	0.5	2.8
Rectum	65.3	2.5	1.0	4.1	65.7	3.5	1.9	5.1
Liver	18.4	-0.8	-3.8	2.1	19.3	1.5	-1.5	4.5
Pancreas	7.4	0.8	-0.2	1.8	7.7	1.4	0.3	2.4
Larynx	62.4	-1.7	-6.6	3.2	62.2	-2.2	-7.1	2.8
Lung and bronchus	19.4	5.7	5.1	6.3	19.1	5.4	4.8	6.0
Skin melanoma	92.2	6.8	5.5	8.1	91.7	6.3	4.8	7.7
Bladder (including in situ)	67.8	-5.0	-6.8	-3.2	68.1	-4.3	-6.1	-2.5
Kidney and renal pelvis	68.0	1.4	-0.4	3.2	68.4	2.8	0.9	4.6
Brain and other nervous system	27.7	4.5	2.5	6.6	27.3	5.5	3.7	7.3
Thyroid	98.8	4.1	2.9	5.4	98.6	3.2	2.0	4.4
Hodgkin lymphoma	87.3	4.2	1.5	6.9	87.1	4.8	2.3	7.3
Non-Hodgkin lymphoma	66.2	3.8	2.4	5.3	66.6	5.8	4.3	7.3
Multiple myeloma	38.9	-1.7	-4.4	1.0	39.1	0.6	-2.0	3.3
Leukemia	56.9	-0.5	-2.4	1.4	56.7	1.1	-0.8	3.0
Other^Note ‡ and unknown	38.9	0.0	-1.0	1.1	38.5	0.8	-0.2	1.8
Note † period method of survival analysis used Return to note † referrer Note ‡ excluding genital system cancers and breast cancer Return to note ‡ referrer Sources: Canadian Cancer Registry database; life tables; Canadian Vital Statistics Death database.

Language selection